Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Total Current Liabilities: 2020-2024

Historic Total Current Liabilities for Agilon Health (AGL) over the last 5 years, with FY2024 value amounting to $1.2 billion.

  • Agilon Health's Total Current Liabilities fell 1201.26% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 1201.26%. This contributed to the annual value of $1.2 billion for FY2024, which is 1789.38% up from last year.
  • Agilon Health's Total Current Liabilities amounted to $1.2 billion in FY2024, which was up 1789.38% from $977.2 million recorded in FY2023.
  • Over the past 5 years, Agilon Health's Total Current Liabilities peaked at $1.2 billion during FY2024, and registered a low of $266.8 million during FY2020.
  • Moreover, its 5-year median value for Total Current Liabilities was $535.1 million (2022), whereas its average is $657.6 million.
  • Per our database at Business Quant, Agilon Health's Total Current Liabilities surged by 8261.49% in 2023 and then soared by 1789.38% in 2024.
  • Over the past 5 years, Agilon Health's Total Current Liabilities (Annual) stood at $266.8 million in 2020, then skyrocketed by 33.78% to $357.0 million in 2021, then soared by 49.9% to $535.1 million in 2022, then surged by 82.61% to $977.2 million in 2023, then rose by 17.89% to $1.2 billion in 2024.
  • Its Total Current Liabilities was $1.2 billion in FY2024, compared to $977.2 million in FY2023 and $535.1 million in FY2022.